Mesalazine-induced lung injury with severe respiratory failure successfully treated with steroids and non-invasive positive pressure ventilation
Drug-induced lung injury (DLI) has become more common because of the increasing number of therapeutic agents in use. Mesalazine, also known as 5-aminosalicylic acid (5-ASA), is one of the key drugs for the treatment of ulcerative colitis (UC). Although mesalazine-induced lung injury has been previou...
Main Authors: | Hajime Oi, Atsushi Suzuki, Yasuhiko Yamano, Toshiki Yokoyama, Toshiaki Matsuda, Kensuke Kataoka, Yasuhiko Suzuki, Tomoki Kimura, Yasuhiro Kondoh |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Respiratory Medicine Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213007120303701 |
Similar Items
-
Acute exacerbation of idiopathic pulmonary fibrosis triggered by Aspergillus empyema
by: Atsushi Suzuki, et al.
Published: (2018-01-01) -
The impact of high-flow nasal cannula oxygen therapy on exercise capacity in fibrotic interstitial lung disease: a proof-of-concept randomized controlled crossover trial
by: Atsushi Suzuki, et al.
Published: (2020-02-01) -
Significance of pulmonary arterial pressure as a prognostic indicator in lung-dominant connective tissue disease.
by: Atsushi Suzuki, et al.
Published: (2014-01-01) -
Mechanisms of Action of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Mesalazine in the Chemoprevention of Colorectal Cancer
by: Giovanni Monteleone, et al.
Published: (2013-09-01) -
Mesalazine-induced Hypersensitivity Pneumonitis
by: Ana Pereira, et al.
Published: (2021-01-01)